FDA Inspection 1111786 — Kovas Co., Ltd.

Kovas Co., Ltd. — FEI 3009640188

The FDA completed an inspection of Kovas Co., Ltd. on November 22, 2019 in Paju. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions were found but do not meet the threshold for regulatory action). 22 citations were issued during this inspection. Product area: Drugs.

Inspection Details

Classification
Voluntary Action Indicated (VAI) (VAI)
End Date
November 22, 2019
Fiscal Year
2020
Product Type
Drugs
Project Area
Drug Quality Assurance
Location
Paju (Korea (the Republic of))

Citations

IDCFRDescription
110521 CFR 211.22(d)Procedures not in writing, fully followed
111221 CFR 211.25(a)Training--operations, GMPs, written procedures
117721 CFR 211.63Equipment Design, Size and Location
121321 CFR 211.67(a)Cleaning / Sanitizing / Maintenance
125621 CFR 211.68(b)Backup file not maintained
126321 CFR 211.68(b)Computer control of master formula records
127021 CFR 211.68(b)input/output verification
178721 CFR 211.80(a)Procedures To Be in Writing
182321 CFR 211.84(c)(4)Top/Middle/Bottom container sampling
184321 CFR 211.84(d)(2)Component written specification
188521 CFR 211.165(b)Microbiological testing
191221 CFR 211.166(a)Written program not followed
197621 CFR 211.182Specific information required in individual logs
200821 CFR 211.186(a)Written procedures followed
202021 CFR 211.188(b)(8)Labeling Control Records and Label Copies
203321 CFR 211.194(c)Testing and standardization of standards et. al.
360321 CFR 211.160(b)Scientifically sound laboratory controls
363221 CFR 211.170(b)Annual visual exams of drug products
434521 CFR 211.160(b)(1)Samples (various types) representative, identified properly
435321 CFR 211.160(b)(4)Instruments, apparatus, et. al. not meeting specs
435921 CFR 211.170(b)(1)Retention time of reserve samples, in general
439921 CFR 211.186(b)(7)Theoretical yield statement including percentages